Cancer doesn’t stop — not even for the novel coronavirus disease, COVID-19. The unknowns related to the virus are leaving people concerned, especially cancer…
Dr. Christopher R. Cogle, Florida Medicaid's Chief Medical Officer and Professor of Medicine at the University of Florida, is a transformative force in health. His pioneering work spans discoveries in basic biology of blood stem cells and leukemia to first-in-human clinical trials for people with cancer and heart diseases, alongside shaping innovative policies in state health and healthcare financing. With over 140 peer-reviewed publications, 70 mentees globally, and two documentaries, Dr. Cogle's influence extends beyond academia. Recognized by prestigious organizations such as the Leukemia & Lymphoma Society, Milbank Memorial Foundation, and the National Academy of Medicine, his accolades highlight his impact in bridging the gap between research and societal change. Dr. Cogle’s career embodies an unwavering commitment to redefining the future of medicine.
Top areas of exploration
- Myelodysplastic Syndromes , 24 publications
- Leukemia, Myeloid, Acute , 24 publications
- Hematopoietic Stem Cell Transplantation , 20 publications
- Hematopoietic Stem Cells , 15 publications
2,573 citationsWhy is this important?
Search our accepted insurances list
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
My areas of focus
Stories and news
University of Florida Health Researcher Combines DNA Sequencing and Cloud Computing to Match Novel Treatments and Leukemia Patients
The University of Florida Health Cancer Center collaborated with the Oregon Health and Sciences University and dozens of other academic medical centers across…